Cargando…
Lowering the Recommended Maximal Wall Thickness Threshold Improves Diagnostic Sensitivity in Asians With Hypertrophic Cardiomyopathy
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is defined as left ventricular end-diastolic maximal wall thickness (WT(Max)) ≥15.0 mm, without accounting for ethnicity, sex, and body size. It is well-established that Asians have smaller hearts than do Caucasians. OBJECTIVES: This study aims to examin...
Autores principales: | Le, Thu-Thao, Huang, Benjamin, Pua, Chee Jian, Tornekar, Vineet, Schumacher-Maurer, Annette, Toh, Desiree-Faye, Bryant, Jennifer, Ang, Briana, Corden, Ben, Prasad, Sanjay K., Tang, Hak-Chiaw, Cook, Stuart A., Chin, Calvin W.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627927/ https://www.ncbi.nlm.nih.gov/pubmed/36338161 http://dx.doi.org/10.1016/j.jacasi.2021.07.001 |
Ejemplares similares
-
Markers of Focal and Diffuse Nonischemic Myocardial Fibrosis Are Associated With Adverse Cardiac Remodeling and Prognosis in Patients With Hypertension: The REMODEL Study
por: Iyer, Nithin R., et al.
Publicado: (2022) -
The application of exercise stress cardiovascular magnetic resonance in patients with suspected dilated cardiomyopathy
por: Le, Thu-Thao, et al.
Publicado: (2020) -
Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study
por: Pua, Chee Jian, et al.
Publicado: (2023) -
Novel Index of Maladaptive Myocardial Remodeling in Hypertension
por: Goh, Vera J., et al.
Publicado: (2017) -
Sacubitril/valsartan versus valsartan in regressing myocardial fibrosis in hypertension: a prospective, randomized, open-label, blinded endpoint clinical trial protocol
por: Lee, Vivian, et al.
Publicado: (2023)